Overview
Moeenaldeen Sayed-Al practices in Riyadh, Saudi Arabia. Sayed-Al is rated as an Experienced expert by MediFind in the treatment of Acid Sphingomyelinase Deficiency (ASMD). Their top areas of expertise are Camptodactyly Taurinuria, Camptodactyly Syndrome Guadalajara Type 1, Camptodactyly Fibrous Tissue Hyperplasia Skeletal Dysplasia, and Camptodactyly Syndrome Guadalajara Type 2.
Their clinical research consists of co-authoring 14 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Acid Sphingomyelinase Deficiency (ASMD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acid Sphingomyelinase Deficiency (ASMD)
- Brachydactyly Mononen TypeSayed-Al isExperienced. Learn about Brachydactyly Mononen Type.
- Camptodactyly Fibrous Tissue Hyperplasia Skeletal Dysplasia
- Camptodactyly Syndrome Guadalajara Type 1
- Camptodactyly Syndrome Guadalajara Type 2
- Camptodactyly TaurinuriaSayed-Al isExperienced. Learn about Camptodactyly Taurinuria.